Racial differences in the prevalence of age-related macular degeneration: The Baltimore Eye Survey

Ophthalmology

Volumn 106, Issue 6, 1999, Pages 1049-1055

  Friedman, David S ^a,b,c   Katz, Joanne ^a,b   Bressler, Neil M ^a   Rahmani, Bahram ^a   Tielsch, James M ^a,b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; DRUSEN; FEMALE; GENETIC PREDISPOSITION; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; REGRESSION ANALYSIS; RETINA MACULA AGE RELATED DEGENERATION;

EID: 0033510538     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-6420(99)90267-1     Document Type: Article

References (25)

1. Sommer A, Tielsch JM, Katz J, et al. Racial differences in the cause-specific prevalence of blindness in east Baltimore. N Engl J Med 1991;325:1412-7.
2. Cooper RL. Blind registrations in Western Australia: a five-year study. Aust N Z J Ophthalmol 1990;18:421-6.
3. Schachat AP, Hyman L, Leske MC, et al. Features of age-related macular degeneration in a black population. The Barbados Eye Study Group. Arch Ophthalmol 1995; 113:728-35.
4. Klein R, Klein BEK, Linton KLP. Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology 1992;99:933-43.
5. Bird AC, Bressler NM, Bressler SB, et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol 1995;39:367-74.
6. Vingerling JR, Dielemans I, Hofman A, et al. The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology 1995;102:205-10.
7. Mitchell P, Smith W, Attebo K, Wang JJ. Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study. Ophthalmology 1995;102:1450-60.
8. Tielsch JM, Sommer A, Witt K, et al. Blindness and visual impairment in an American urban population. The Baltimore Eye Survey. Arch Ophthalmol 1990;108:286-90.
9. Tielsch JM, Sommer A, Katz J, et al. Racial variations in the prevalence of primary open-angle glaucoma. The Baltimore Eye Survey. JAMA 1991;266:369-74.
10. Ferris FL III, Kassoff A, Bresnick GH, Bailey I. New visual acuity charts for clinical research. Am J Ophthalmol 1982;94: 91-6.
11. Ferris FL III, Sperduto RD. Standardized illumination for visual acuity testing in clinical research. Am J Ophthalmol 1982;94:97-8.
12. Bressler NM, Bressler SB, West SK, et al. The grading and prevalence of macular degeneration in Chesapeake Bay watermen. Arch Ophthalmol 1989;107:847-52.
13. Cuzick J. A Wilcoxon-type test for trend. Stat Med 1985;4: 87-90.
14. Kahn HA, Sempos CT. Statistical Methods in Epidemiology. New York: Oxford University Press, 1989;85-136. (Monographs in Epidemiology and Biostatistics; v. 12).
15. Wang Q, Chappell RJ, Klein R, et al. Pattern of age-related maculopathy in the macular area. The Beaver Dam Eye Study. Invest Ophthalmol Vis Sci 1996;37:2234-42.
16. Bressler SB, Maguire MG, Bressler NM, Fine SL. Relationship of drusen and abnormalities of the retinal pigment epithelium to the prognosis of neovascular macular degeneration. The Macular Photocoagulation Study Group. Arch Ophthalmol 1990;108:1442-7.
17. Leske MC, Connell AMS, Schachat AP, Hyman L. The Barbados Eye Study. Prevalence of open angle glaucoma. Arch Ophthalmol 1994;112:821-9.
18. Jampol LM, Tielsch JM. Race, macular degeneration, and the Macular Photocoagulation Study [editorial]. Arch Ophthalmol 1992;110:1699-700.
19. Pieramici DJ, Bressler NM, Bressler SB, Schachat AP. Choroidal neovascularization in black patients. Arch Ophthalmol 1994;112:1043-6.
20. Capone AJ Jr, Wallace RT, Meredith TA. Symptomatic choroidal neovascularization in blacks. Arch Ophthalmol 1994; 112:1091-7.
21. Hyman LG, Lilienfeld AM, Ferris FL III, Fine SL. Senile macular degeneration: a case-control study. Am J Epidemiol 1983;118:213-27.
22. Kahn HA, Leibowitz HM, Ganley JP, et al. The Framingham Eye Study. II. Association of ophthalmic pathology with single variables previously measured in the Framingham Heart Study. Am J Epidemiol 1977;106:33-41.
23. Klein R, Klein BEK, Jensen SC. The relation of cardiovascular disease and its risk factors to the 5-year incidence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology 1997;104:1804-12.
24. Smith W, Mitchell P, Leeder SR, Wang JJ. Plasma fibrinogen levels, other cardiovascular risk factors, and age-related maculopathy: the Blue Mountains Eye Study. Arch Ophthalmol 1998;116:583-7.
25. Klein R, Klein BEK, Moss SE. Age-related eye disease and survival. The Beaver Dam Eye Study. Arch Ophthalmol 1995; 113:333-9.